ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; sodium chloride; disodium edetate; citric acid; water for injections - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 426.4 mg (equivalent: lidocaine hydrochloride, qty 400 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.64 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.6 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zinc oxide, quantity: 350 mg/g; cod-liver oil, quantity: 220 mg/g (equivalent: vitamin a, qty 40 re/g; equivalent: colecalciferol, qty 6.25 microgram/g) - cream - excipient ingredients: ethyl hydroxybenzoate; propyl hydroxybenzoate; liquid paraffin; methyl hydroxybenzoate; white beeswax; wool fat; eugenol - decrease/reduce/relieve symptoms of mild eczema/dermatitis ; decrease/reduce/relieve skin irritation ; decrease/reduce/relieve symptoms of nappy rash ; helps decrease/reduce/relieve symptoms of minor skin wounds (cuts, scratches and abrasions) ; soothe/relieve mild skin burn/sunburns

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.